Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2008-08-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)
NCT01937195
USING THE ACCUVEIN DEVICE FOR PATIENTS WHO ARE DIFFICULT TO PERFUSE
NCT06861595
FastWire REvascularisation of Extremities, (For LOWer Limbs) - Feasibility Study (FREEFLOW)
NCT05869435
The Clinical Efficacy of Midline Catheters
NCT03457259
ReFlow Medical Wingman Catheter Wing-IT Clinical Trial
NCT03403426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ClearWay™ RX
ClearWay™ RX Local Therapeutic Infusion Catheter
The ClearWay™ RX Local Therapeutic Infusion Catheter is a micro-porous PTFE balloon catheter designed for the localized infusion of various diagnostic and therapeutic agents into the coronary and peripheral vasculature.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ClearWay™ RX Local Therapeutic Infusion Catheter
The ClearWay™ RX Local Therapeutic Infusion Catheter is a micro-porous PTFE balloon catheter designed for the localized infusion of various diagnostic and therapeutic agents into the coronary and peripheral vasculature.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Atrium Medical Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ron Waksman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Medstar Health Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Escondido Cardiology Associates
Escondido, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Winter Haven Florida
Winter Haven, Florida, United States
The Georgia Heart Center
Macon, Georgia, United States
Clarian Health Partners Methodist Research Institute
Indianapolis, Indiana, United States
Western Baptist Hospital
Paducah, Kentucky, United States
Genesys Regional Medical Center
Grand Blanc, Michigan, United States
Great Lakes Heart & Vascular Institute
Saint Joseph, Michigan, United States
St.Mary's Duluth Clinic Health System
Duluth, Minnesota, United States
Presbyterian Hospital Mid-Carolina Cardiology
Charlotte, North Carolina, United States
Forsyth Medical Center-Cardiovascular Research
Winston-Salem, North Carolina, United States
Good Samaritan Hospital
Lebanon, Pennsylvania, United States
Virginia Cardiovascular Specialists
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20080711
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.